98 related articles for article (PubMed ID: 6788841)
1. Evidence for T cell nature and heterogeneity within natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) effectors: a comparison with cytolytic T lymphocytes (CTL).
Fast LD; Hansen JA; Newman W
J Immunol; 1981 Aug; 127(2):448-52. PubMed ID: 6788841
[No Abstract] [Full Text] [Related]
2. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
Dato ME; Kim YB
J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P
Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
[TBL] [Abstract][Full Text] [Related]
4. A comparison of membrane markers on rat cytotoxic cells.
Cantrell DA; Robins RA; Baldwin RW
Immunology; 1983 May; 49(1):139-46. PubMed ID: 6220963
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies which react with lymphocyte-lysed target cells and which cross-react with complement-lysed ghosts.
Ward RH; Lachmann PJ
Immunology; 1985 Sep; 56(1):179-88. PubMed ID: 4043993
[TBL] [Abstract][Full Text] [Related]
6. Studies of human natural killer cells. III. Neutropenia associated with unusual characteristics of antibody-dependent and natural killer cell-mediated cytotoxicity.
Pross HF; Pater J; Dwosh I; Giles A; Gallinger LA; Rubin P; Corbett WE; Galbraith P; Baines MG
J Clin Immunol; 1982 Apr; 2(2):126-34. PubMed ID: 6978346
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
8. T cell nature and heterogeneity of recognition structures of human natural killer (NK) cells.
Fast LD; Beatty P; Hansen JA; Newman W
J Immunol; 1983 Nov; 131(5):2404-10. PubMed ID: 6415167
[TBL] [Abstract][Full Text] [Related]
9. Identification and separation of Thy-1 positive mouse spleen cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity.
Mattes MJ; Sharrow SO; Herberman RB; Holden HT
J Immunol; 1979 Dec; 123(6):2851-60. PubMed ID: 387876
[TBL] [Abstract][Full Text] [Related]
10. CD2 and other surface molecules in the regulation of non-MHC-restricted cytolytic function.
Chan WC; Ye G; Link S; Mawle AC; Nicholson JK
Immunology; 1989 May; 67(1):56-61. PubMed ID: 2567703
[TBL] [Abstract][Full Text] [Related]
11. Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen.
Phillips JH; Lanier LL
J Immunol; 1986 Mar; 136(5):1579-85. PubMed ID: 2419407
[TBL] [Abstract][Full Text] [Related]
12. Modulation of cytotoxic T lymphocyte, natural killer cell, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by Vernonia cinerea L. and vernolide-A in BALB/c mice via enhanced production of cytokines IL-2 and IFN-γ.
Pratheeshkumar P; Kuttan G
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):46-55. PubMed ID: 22176676
[TBL] [Abstract][Full Text] [Related]
13. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
[TBL] [Abstract][Full Text] [Related]
14. Preservation of natural killer and interleukin-2 activated killer cell activity in ataxia-telangiectasia with T cell deficiency.
Tsuge I; Matsuoka H; Torii S; Okada J; Mizuno T; Matsuoka M; Kodera Y; Takahashi T
J Clin Lab Immunol; 1987 May; 23(1):7-13. PubMed ID: 3497277
[TBL] [Abstract][Full Text] [Related]
15. Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.
Liu Z; Lee FT; Hanai N; Smyth FE; Burgess AW; Old LJ; Scott AM
Cancer Immun; 2002 Oct; 2():13. PubMed ID: 12747758
[TBL] [Abstract][Full Text] [Related]
16. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
Woodhouse CS; Morgan AC
Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
[TBL] [Abstract][Full Text] [Related]
17. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R
J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198
[TBL] [Abstract][Full Text] [Related]
18. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
[TBL] [Abstract][Full Text] [Related]
19. Aging influence on the E-rosette forming cells, spontaneous cell mediated cytotoxicity, and antibody dependent cellular cytotoxicity in humans.
Olinescu A; Hristescu S; Poliopol M; Vasiliu E; Saragea M; Saragea A; Perieteanu R
Arch Immunol Ther Exp (Warsz); 1987; 35(1):1-10. PubMed ID: 3498459
[TBL] [Abstract][Full Text] [Related]
20. Natural killer and antibody-dependent cytotoxic activities in T cell chronic lymphocytic leukemia.
Gupta S; Fernandes G
J Clin Lab Immunol; 1983 Nov; 12(3):155-7. PubMed ID: 6607357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
